During the past decade, AOU Maggiore della Caritá conducted 126 clinical trials. In the 10-year time frame, 126 clinical trials started and 39 clinical trials were completed, i.e. on average, 31% percent of trials that started reached the finish line to date. In the past 5 years, 67 clinical trials started and 24 clinical trials were completed. i.e. 35.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AOU Maggiore della Caritá" #1 sponsor was "Azienda Ospedaliero Universitaria Maggiore della Carita" with 20 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 7 trials sponsored, "Hoffmann-La Roche" with 7 trials sponsored, "Janssen Research & Development, LLC" with 7 trials sponsored and "Shire" with 7 trials sponsored. Other sponsors include 136 different institutions and companies that sponsored additional 92 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AOU Maggiore della Caritá" #1 collaborator was "Azienda Ospedaliero Universitaria Maggiore della Carita" with 4 trials as a collaborator, "Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte" with 3 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico" with 2 trials as a collaborator and "Fondazione Italiana Linfomi ONLUS" with 2 trials as a collaborator. Other collaborators include 64 different institutions and companies that were collaborators in the rest 69 trials.

According to Clinical.Site data, the most researched conditions in "AOU Maggiore della Caritá" are "Multiple Myeloma" (10 trials), "Coronary Artery Disease" (6 trials), "Leukemia" (5 trials), "Carcinoma, Non-Small-Cell Lung" (4 trials) and "Chronic Lymphocytic Leukemia" (4 trials). Many other conditions were trialed in "AOU Maggiore della Caritá" in a lesser frequency.

Most popular intervention types in "AOU Maggiore della Caritá" are "Drug" (133 trials), "Other" (24 trials), "Device" (17 trials), "Biological" (11 trials) and "Procedure" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "Rituximab" (9 trials), "Docetaxel" (7 trials), "Dexamethasone" (6 trials) and "Atezolizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "AOU Maggiore della Caritá" are 180 trials for "All" genders, 5 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "AOU Maggiore della Caritá". undefined are not yet recruiting, 41 are recruiting, 30 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 71 completed trials in AOU Maggiore della Caritá, undefined suspended trials, and 20 terminated clinical trials to date.

Out of the total trials that were conducted in AOU Maggiore della Caritá, 2 "Phase 1" clinical trials were conducted, 48 "Phase 2" clinical trials and 83 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 17 trials that are defined as “Not Applicable".

AOU Maggiore della Caritá has several departments that took part in Clinical trials: "Aou Maggiore Della Carita' - Cardiologia Ii" - 8 trials, "Ospedale Maggiore Della Carita; Oncologia Medica" - 8 trials, "AOU Maggiore della Carità - Clinica Pediatrica - Ambulatorio di Auxologia ed Endocrinologia Pediatrica" - 6 trials